SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

CFRA Maintains Buy on Bristol-Myers Squibb, Raises Price Target to $70

CFRA analyst Sel Hardy maintains Bristol-Myers Squibb (NYSE:BMY) with a Buy and raises the price target from $69 to $70.

Benzinga · 05/07/2020 17:50

CFRA analyst Sel Hardy maintains Bristol-Myers Squibb (NYSE:BMY) with a Buy and raises the price target from $69 to $70.